Women in England with incurable breast cancer to get life-extending drug on NHS

Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price Thousands of women in England with incurable breast cancer will get access to a life-extending drug on the NHS after negotiations over its cost proved successful. About 1,000 women a year with HER2-low advanced breast cancer will be able to obtain Enhertu from Thursday after ministers and the drug’s makers…

Coverage from 3 publishers 3 source reports

GuardianSkyBBC

Life-extending drug for breast cancer patients now on NHS

Update summary

What changed in this update

Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.

Source coverage

Source reports

Guardian Published 17 September 2026

Women in England with incurable breast cancer to get life-extending drug on NHS

Sky Published 17 September 2026

Life-extending drug for breast cancer patients now on NHS

A life-extending drug will be made available on the NHS to patients in England with a specific type of incurable breast cancer, after an initial decision to reject the treatment was reversed.

BBC Published 16 September 2026

New hope for breast cancer patients as life-extending drug now on NHS in England

Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two years and is available.

Discovery

See what’s emerging. See what’s changing.

Explore stories gaining momentum and continuing events with new developments.

Explore Discovery